New low dose depot medroxyprogesterone acetate subcutaneous injection is equivalent to leuprolide acetate for endometriosis-associated pain

In: Fertility and Sterility · 2004 · vol. 82 , pp. S71 · doi:10.1016/j.fertnstert.2004.07.182 · W2150381486
article OA: closed CC0 ⤵ 1 in-corpus citation
⚙ AI-generated summary by qwen3.7-flash, 2026-08-21 ⓘ

This research demonstrates that a new low-dose depot medroxyprogesterone acetate subcutaneous injection is equivalent to leuprolide acetate for managing pain associated with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-19T06:31:22.526400+00:00
License: CC0 · commercial use OK